Overview
Philosophy of care | In my area we’re dealing with people who are frightened. I’m trying to help patients deal with all of the information they’ve been hearing, and I’m trying to dispel all of the myths. It’s a matter of education and mutual trust. I’m there to do whatever I can do for them, even if it’s just a matter of easing their pain. | Also, I am a member of the thoracic cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | Medicine was not my first choice. I wanted to be first oboe in the New York Philharmonic. I have a love of biochemistry and science, and I like people. One day, I just decided I wanted to be a doctor. I wouldn’t change it for anything in the world. | Community involvement | I’m part of the National Cancer Institute’s community cancer program. Our goal is to be able to give the same care and treatment to everyone, whether they have health insurance or not. | Personal interests | I still play the oboe and will always have a love of music. I’m an avid cyclist, and I enjoy skiing.
Dr. Friedman is highly rated in 31 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Bone Marrow Aspiration.
His clinical research consists of co-authoring 7 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1240 S Cedar Crest Blvd, Suite 401, Allentown, PA 18103
Additional Areas of Focus
Dr. Friedman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Rutgers Cancer Institute Of New Jersey
Matthew Matasar is a Hematologist and an Oncologist in New Brunswick, New Jersey. Dr. Matasar is highly rated in 26 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Matasar is currently accepting new patients.
Office
Janet Kwiatkowski is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Kwiatkowski is highly rated in 14 conditions, according to our data. Her top areas of expertise are Hemolytic Anemia, Congenital Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.
Fox Chase Cancer Center
Daniel Geynisman is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Frequently Asked Questions about Dr. Eliot L. Friedman
How do I make an appointment with Dr. Eliot L. Friedman?
You can book an appointment with Dr. Eliot L. Friedman by calling their office at 610-402-7880. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Eliot L. Friedman a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eliot L. Friedman is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Eliot L. Friedman specialize in?
While Dr. Eliot L. Friedman is a Hematology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Eliot L. Friedman participate in research or clinical trials?
Yes. Dr. Eliot L. Friedman has published 7 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Eliot L. Friedman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Eliot L. Friedman accept my insurance?
Dr. Eliot L. Friedman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 610-402-7880 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Friedman isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Friedman isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Friedman isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Friedman isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Friedman isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Friedman isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- AstrocytomaDr. Friedman isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Chronic B-Cell Leukemia (CBCL)Dr. Friedman isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Friedman isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- DehydrationDr. Friedman isAdvanced. Learn about Dehydration.
- Embryonal Tumor with Multilayered Rosettes
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Friedman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Friedman isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Friedman isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Friedman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Friedman isExperienced. Learn about Acute Promyelocytic Leukemia.